Recombinant multi-species CIDEA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CIDEA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the homolog of the mouse protein Cidea that has been shown to activate apoptosis. This activation of apoptosis is inhibited by the DNA fragmentation factor DFF45 but not by caspase inhibitors. Mice that lack functional Cidea have higher metabolic rates, higher lipolysis in brown adipose tissue and higher core body temperatures when subjected to cold. These mice are also resistant to diet-induced obesity and diabetes. This suggests that in mice this gene product plays a role in thermogenesis and lipolysis. Alternatively spliced transcripts have been identified. [provided by RefSeq, Aug 2010]
The Alternative Names of target: CIDE-A,CIDEA,Cell death activator CIDE-A,Cell death-inducing DFFA-like effector A,Cidea,Lipid transferase CIDEA

Target products collectionGo to CIDEA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP4179-Ag-1/ GM-Tg-hg-IP4179-Ag-2 Human CIDEA protein Human
GM-Tg-rg-IP4179-Ag-1/ GM-Tg-rg-IP4179-Ag-2 Rat CIDEA protein Rat
GM-Tg-mg-IP4179-Ag-1/ GM-Tg-mg-IP4179-Ag-2 Mouse CIDEA protein Mouse
GM-Tg-cynog-IP4179-Ag-1/ GM-Tg-cynog-IP4179-Ag-2 Cynomolgus/Rhesus macaque CIDEA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP4179-Ag-1/ GM-Tg-felg-IP4179-Ag-2 Feline CIDEA protein Feline
GM-Tg-cang-IP4179-Ag-1/ GM-Tg-cang-IP4179-Ag-2 Canine CIDEA protein Canine
GM-Tg-bovg-IP4179-Ag-1/ GM-Tg-bovg-IP4179-Ag-2 Bovine CIDEA protein Bovine
GM-Tg-equg-IP4179-Ag-1/ GM-Tg-equg-IP4179-Ag-2 Equine CIDEA protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP4179-Ag-1/ GM-Tg-hg-IP4179-Ag-2; GM-Tg-rg-IP4179-Ag-1/ GM-Tg-rg-IP4179-Ag-2;
GM-Tg-mg-IP4179-Ag-1/ GM-Tg-mg-IP4179-Ag-2; GM-Tg-cynog-IP4179-Ag-1/ GM-Tg-cynog-IP4179-Ag-2;
GM-Tg-felg-IP4179-Ag-1/ GM-Tg-felg-IP4179-Ag-2; GM-Tg-cang-IP4179-Ag-1/ GM-Tg-cang-IP4179-Ag-2;
GM-Tg-bovg-IP4179-Ag-1/ GM-Tg-bovg-IP4179-Ag-2; GM-Tg-equg-IP4179-Ag-1/ GM-Tg-equg-IP4179-Ag-2
Products Name CIDEA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CIDEA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CIDEA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.